Shuttle Pharmaceuticals (SHPH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.08, -8.80% vs the prior close of $5.57.
- Volume 12.53K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SHPH slides 8.8% to $5.08. Closed at $5.08, -8.80% vs the prior close of $5.57. Day range $5.08–$5.39, opened at $5.20.
SHPH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SHPH slides 8.8% to $5.08
- Closed at $5.08, -8.80% vs the prior close of $5.57. Day range $5.08–$5.39, opened at $5.20.
- Volume was 12.53K shares, 0.3x its 50-day average of 48.65K — lighter than usual.
- Price is +26.8% vs its 50-day average ($4.01) and -33.9% vs its 200-day average ($7.69).
- 52-week range $2.58–$44.40; today's close sits at 6% of that range, 88.6% below the 52-week high.
Oct 15, 2026 — SHPH jumps 6.3% to $5.57, a 3-month high
- Closed at $5.57, +6.30% vs the prior close of $5.24. Day range $5.25–$5.68, opened at $5.25.
- Volume was 35.10K shares, 0.4x its 50-day average of 79.81K — lighter than usual.
- Price is +39.5% vs its 50-day average ($3.99) and -28.2% vs its 200-day average ($7.75).
- 52-week range $2.58–$44.40; today's close sits at 7% of that range, 87.5% below the 52-week high.
Oct 14, 2026 — SHPH rises 1.2% to $5.24
- Closed at $5.24, +1.16% vs the prior close of $5.18. Day range $4.83–$5.36, opened at $5.14.
- Volume was 41.90K shares, 0.5x its 50-day average of 81.33K — lighter than usual.
- Price is +31.9% vs its 50-day average ($3.97) and -32.9% vs its 200-day average ($7.81).
- 52-week range $2.58–$44.40; today's close sits at 6% of that range, 88.2% below the 52-week high.
Oct 13, 2026 — SHPH slides 5.0% to $5.18
- Closed at $5.18, -4.95% vs the prior close of $5.45. Day range $5.05–$5.56, opened at $5.44.
- Volume was 19.90K shares, 0.2x its 50-day average of 84.63K — lighter than usual.
- Price is +31.5% vs its 50-day average ($3.94) and -34.2% vs its 200-day average ($7.88).
- 52-week range $2.58–$44.40; today's close sits at 6% of that range, 88.3% below the 52-week high.
Oct 12, 2026 — SHPH rises 2.3% to $5.45
- Closed at $5.45, +2.25% vs the prior close of $5.33. Day range $5.36–$5.64, opened at $5.36.
- Volume was 21.30K shares, 0.1x its 50-day average of 145.65K — lighter than usual.
- Price is +39.6% vs its 50-day average ($3.90) and -31.4% vs its 200-day average ($7.94).
- 52-week range $2.58–$55.90; today's close sits at 5% of that range, 90.3% below the 52-week high.
Oct 9, 2026 — SHPH slides 4.0% to $5.33
- Closed at $5.33, -3.96% vs the prior close of $5.55. Day range $5.11–$5.47, opened at $5.32.
- Volume was 29.00K shares, 0.2x its 50-day average of 149.10K — lighter than usual.
- Price is +37.7% vs its 50-day average ($3.87) and -33.4% vs its 200-day average ($8.00).
- 52-week range $2.58–$55.90; today's close sits at 5% of that range, 90.5% below the 52-week high.
Oct 8, 2026 — SHPH jumps 17.8% to $5.55, a 3-month high on 1.9x normal volume
- Closed at $5.55, +17.83% vs the prior close of $4.71. Day range $4.81–$5.75, opened at $4.90.
- Volume was 281.70K shares, 1.9x its 50-day average of 147.61K — unusually heavy trading.
- Price is +45.0% vs its 50-day average ($3.83) and -31.2% vs its 200-day average ($8.07).
- 52-week range $2.58–$55.90; today's close sits at 6% of that range, 90.1% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — SHPH jumps 16.0% to $4.71, a 3-month high
- Closed at $4.71, +16.01% vs the prior close of $4.06. Day range $4.01–$4.75, opened at $4.01.
- Volume was 116.00K shares, 0.8x its 50-day average of 146.63K.
- Price is +24.9% vs its 50-day average ($3.77) and -42.0% vs its 200-day average ($8.13).
- 52-week range $2.58–$55.90; today's close sits at 4% of that range, 91.6% below the 52-week high.
Oct 6, 2026 — SHPH rises 1.2% to $4.06
- Closed at $4.06, +1.25% vs the prior close of $4.01. Day range $3.95–$4.17, opened at $4.03.
- Volume was 16.60K shares, 0.1x its 50-day average of 148.76K — lighter than usual.
- Price is +8.8% vs its 50-day average ($3.73) and -50.4% vs its 200-day average ($8.19).
- 52-week range $2.58–$55.90; today's close sits at 3% of that range, 92.7% below the 52-week high.
Oct 5, 2026 — SHPH slides 3.8% to $4.01
- Closed at $4.01, -3.84% vs the prior close of $4.17. Day range $3.91–$4.10, opened at $4.01.
- Volume was 13.30K shares, 0.1x its 50-day average of 150.29K — lighter than usual.
- Price is +8.1% vs its 50-day average ($3.71) and -51.4% vs its 200-day average ($8.25).
- 52-week range $2.58–$55.90; today's close sits at 3% of that range, 92.8% below the 52-week high.
Oct 2, 2026 — SHPH jumps 5.6% to $4.17, a 1-month high
- Closed at $4.17, +5.57% vs the prior close of $3.95. Day range $3.91–$4.17, opened at $3.98.
- Volume was 4.40K shares, 0.0x its 50-day average of 152.47K — lighter than usual.
- Price is +13.1% vs its 50-day average ($3.69) and -49.9% vs its 200-day average ($8.32).
- 52-week range $2.58–$55.90; today's close sits at 3% of that range, 92.5% below the 52-week high.
SHPH latest news & SEC filings
Every SEC filing by or about SHPH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.15M (prior year -$3.71M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$3.10 (prior year -$32.91) (loss narrowed vs Jun 30, 2025)
Sep 24, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 2, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 17, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 2.01 — Completed an acquisition or sale of assets.
Aug 13, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 13, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 3, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hrt Financial Lp sold 82,116 shares at $4.48 (≈$367.88K) on Jul 14, 2026
- Hrt Financial Lp sold 82,116 shares at $4.48 (≈$367.88K) on Jul 14, 2026
- Hrt Financial Lp sold 82,116 shares at $4.48 (≈$367.88K) on Jul 14, 2026
- Hrt Financial Lp sold 82,116 shares at $4.48 (≈$367.88K) on Jul 14, 2026
- Hrt Financial Lp sold 1,033 shares at $4.67 (≈$4.82K) on Jul 13, 2026
- Hrt Financial Lp sold 1,033 shares at $4.67 (≈$4.82K) on Jul 13, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hrt Financial Lp bought 731 shares at $3.11 (≈$2.27K) on Jul 10, 2026
- Hrt Financial Lp bought 731 shares at $3.11 (≈$2.27K) on Jul 10, 2026
- Hrt Financial Lp bought 731 shares at $3.11 (≈$2.27K) on Jul 10, 2026
- Hrt Financial Lp bought 731 shares at $3.11 (≈$2.27K) on Jul 10, 2026
- Hrt Financial Lp bought 8,266 shares at $3.38 (≈$27.94K) on Jul 9, 2026
- Hrt Financial Lp bought 8,266 shares at $3.38 (≈$27.94K) on Jul 9, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade SHPH
- Last results release: Feb 17, 2026 (8-K Item 2.02). Previous ones: Feb 26, 2025, Nov 13, 2024, May 14, 2024. Based on that rhythm, the next report is likely around May 19, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.85% (largest 17.8%). That is a volatile stock.
- Liquidity: about 46.22K shares (≈$234.78K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.08 vs a range of $2.58–$44.40 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jun 11, 2026, 1:25 on Jun 16, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 17 sales; latest: Financial Lp Hrt sold 82,116 shares on Jul 14, 2026.
- Latest filings: 10-Q Sep 24, 2026; 8-K Sep 16, 2026; 8-K Sep 11, 2026.
- Share count: 4.76M shares outstanding (Sep 21, 2026), +345.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SHPH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.20 | 5.39 | 5.08 | 5.08 | 12.53K |
| Oct 15, 2026 | 5.25 | 5.68 | 5.25 | 5.57 | 35.10K |
| Oct 14, 2026 | 5.14 | 5.36 | 4.83 | 5.24 | 41.90K |
| Oct 13, 2026 | 5.44 | 5.56 | 5.05 | 5.18 | 19.90K |
| Oct 12, 2026 | 5.36 | 5.64 | 5.36 | 5.45 | 21.30K |
| Oct 9, 2026 | 5.32 | 5.47 | 5.11 | 5.33 | 29.00K |
| Oct 8, 2026 | 4.90 | 5.75 | 4.81 | 5.55 | 281.70K |
| Oct 7, 2026 | 4.01 | 4.75 | 4.01 | 4.71 | 116.00K |
| Oct 6, 2026 | 4.03 | 4.17 | 3.95 | 4.06 | 16.60K |
| Oct 5, 2026 | 4.01 | 4.10 | 3.91 | 4.01 | 13.30K |
| Oct 2, 2026 | 3.98 | 4.17 | 3.91 | 4.17 | 4.40K |
| Oct 1, 2026 | 4.04 | 4.08 | 3.94 | 3.95 | 12.30K |
| Sep 30, 2026 | 3.91 | 4.22 | 3.91 | 4.04 | 31.20K |
| Sep 29, 2026 | 3.96 | 4.04 | 3.85 | 3.92 | 16.50K |
| Sep 28, 2026 | 3.99 | 4.12 | 3.84 | 4.11 | 31.30K |
| Sep 25, 2026 | 3.87 | 4.22 | 3.87 | 4.01 | 20.90K |
| Sep 24, 2026 | 3.59 | 4.09 | 3.50 | 4.00 | 48.40K |
| Sep 23, 2026 | 3.70 | 3.90 | 3.51 | 3.59 | 49.00K |
| Sep 22, 2026 | 3.41 | 4.10 | 3.32 | 3.76 | 87.50K |
| Sep 21, 2026 | 3.21 | 3.59 | 3.21 | 3.47 | 35.50K |
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals (SHPH) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in GAITHERSBURG, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1757499.
SHPH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Angel Liriano | Director | Oct 29, 2025 |
| Arachchige Sachin Eranga Pathigoda | Director | Oct 28, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yuying Liang | Chief Financial Officer | Jan 12, 2026 |
| Ryan Trasolini | Co-Chief Executive Officer | Jun 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 14, 2026 | Financial Lp Hrt | Sale | 82,116 | $4.48 |
| Jul 14, 2026 | Financial Lp Hrt | Sale | 82,116 | $4.48 |
| Jul 14, 2026 | Financial Lp Hrt | Sale | 82,116 | $4.48 |
| Jul 14, 2026 | Financial Lp Hrt | Sale | 82,116 | $4.48 |
| Jul 13, 2026 | Financial Lp Hrt | Sale | 1,033 | $4.67 |
| Jul 13, 2026 | Financial Lp Hrt | Sale | 1,033 | $4.67 |
| Jul 13, 2026 | Financial Lp Hrt | Sale | 1,033 | $4.67 |
| Jul 13, 2026 | Financial Lp Hrt | Sale | 1,033 | $4.67 |
| Jul 10, 2026 | Financial Lp Hrt | Buy | 731 | $3.11 |
| Jul 10, 2026 | Financial Lp Hrt | Buy | 731 | $3.11 |
| Jul 10, 2026 | Financial Lp Hrt | Buy | 731 | $3.11 |
| Jul 10, 2026 | Financial Lp Hrt | Buy | 731 | $3.11 |
| Jul 9, 2026 | Financial Lp Hrt | Buy | 8,266 | $3.38 |
| Jul 9, 2026 | Financial Lp Hrt | Buy | 8,266 | $3.38 |
| Jul 9, 2026 | Financial Lp Hrt | Buy | 8,266 | $3.38 |
SHPH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-11.72M | -7.16 | $-9.48M |
| Dec 31, 2024 | — | $-9.14M | -82.60 | $-7.33M |
| Dec 31, 2023 | — | $-6.59M | -3.53 | $-5.58M |
| Dec 31, 2022 | — | $-3.03M | -0.29 | $-2.71M |
| Dec 31, 2021 | — | $-1.15M | — | $-300.34K |
Latest balance sheet: total assets $22.81M, total liabilities $3.63M, cash $90.24K (as of Jun 30, 2026).
SHPH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Feb 17, 2026 | 8-K Item 2.02 (results) | $10.80 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $150.00 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $277.50 |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 22, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 15, 2023 | 8-K Item 2.02 (results) | — |
| May 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SHPH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.